Burns J W & CO Inc Novartis Ag Transaction History

Burns J W & CO Inc

$767 Million
Q3 2024

A detailed history of Burns J W & CO Inc transactions in Novartis Ag stock. As of the latest transaction made, Burns J W & CO Inc holds 8,009 shares of NVS stock, worth $835,178. This represents 0.12% of its overall portfolio holdings.

Number of Shares

8,009

Previous 8,084 0.93%

Holding current value

$835,178

Previous $860,000 7.09%

% of portfolio

0.12%

Previous 0.12%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	SELL	$106.13 - $120.89 $7,959 - $9,066	-75 Reduced 0.93%	8,009 $921,000
Q1 2024 Apr 17, 2024	BUY	$95.27 - $108.47 $16,195 - $18,439	170 Added 2.15%	8,084 $781,000
Q4 2023 Jan 18, 2024	BUY	$92.27 - $101.54 $27,681 - $30,462	300 Added 3.94%	7,914 $799,000
Q3 2023 Nov 13, 2023	SELL	$94.73 - $105.13 $18,946 - $21,026	-200 Reduced 2.56%	7,614 $775,000
Q1 2023 Apr 17, 2023	SELL	$80.03 - $92.81 $17,126 - $19,861	-214 Reduced 2.67%	7,814 $719,000
Q4 2022 Jan 13, 2023	SELL	$75.55 - $92.52 $41,174 - $50,423	-545 Reduced 6.36%	8,028 $728,000
Q3 2022 Oct 04, 2022	SELL	$74.61 - $87.26 $42,527 - $49,738	-570 Reduced 6.23%	8,573 $652,000
Q2 2022 Jul 14, 2022	SELL	$80.52 - $93.75 $58,779 - $68,437	-730 Reduced 7.39%	9,143 $773,000
Q1 2022 Apr 08, 2022	SELL	$80.11 - $90.62 $70,817 - $80,108	-884 Reduced 8.22%	9,873 $866,000
Q4 2021 Jan 20, 2022	SELL	$79.7 - $88.13 $10,759 - $11,897	-135 Reduced 1.24%	10,757 $941,000
Q3 2021 Oct 13, 2021	SELL	$81.78 - $95.14 $169,039 - $196,654	-2,067 Reduced 15.95%	10,892 $891,000
Q2 2021 Jul 12, 2021	BUY	$85.24 - $94.15 $21,395 - $23,631	251 Added 1.98%	12,959 $1.18 Million
Q1 2021 Apr 16, 2021	SELL	$83.5 - $98.47 $110,888 - $130,768	-1,328 Reduced 9.46%	12,708 $1.09 Million
Q4 2020 Jan 12, 2021	SELL	$78.07 - $94.43 $22,640 - $27,384	-290 Reduced 2.02%	14,036 $1.33 Million
Q3 2020 Oct 06, 2020	SELL	$82.14 - $91.0 $23,409 - $25,935	-285 Reduced 1.95%	14,326 $1.25 Million
Q2 2020 Jul 06, 2020	SELL	$80.93 - $91.1 $2,023 - $2,277	-25 Reduced 0.17%	14,611 $1.28 Million
Q1 2020 Apr 06, 2020	SELL	$70.67 - $99.01 $49,398 - $69,207	-699 Reduced 4.56%	14,636 $1.21 Million
Q4 2019 Jan 07, 2020	SELL	$84.35 - $95.37 $19,906 - $22,507	-236 Reduced 1.52%	15,335 $1.45 Million
Q3 2019 Oct 11, 2019	SELL	$85.54 - $94.26 $13,686 - $15,081	-160 Reduced 1.02%	15,571 $1.35 Million
Q2 2019 Jul 09, 2019	BUY	$75.4 - $92.8 $15,080 - $18,560	200 Added 1.29%	15,731 $1.44 Million
Q1 2019 Apr 02, 2019	SELL	$75.32 - $86.15 $24,930 - $28,515	-331 Reduced 2.09%	15,531 $1.49 Million
Q4 2018 Jan 16, 2019	SELL	$73.66 - $82.02 $28,727 - $31,987	-390 Reduced 2.4%	15,862 $1.36 Million
Q3 2018 Oct 05, 2018	SELL	$66.94 - $77.43 $44,113 - $51,026	-659 Reduced 3.9%	16,252 $1.4 Million
Q2 2018 Jul 20, 2018	SELL	$64.91 - $73.36 $108,659 - $122,804	-1,674 Reduced 9.01%	16,911 $1.28 Million
Q1 2018 Apr 04, 2018	SELL	$70.39 - $84.15 $29,915 - $35,763	-425 Reduced 2.24%	18,585 $1.5 Million
Q4 2017 Jan 17, 2018	SELL	$72.33 - $77.64 $15,550 - $16,692	-215 Reduced 1.12%	19,010 $1.6 Million
Q3 2017 Oct 10, 2017	BUY	$74.14 - $77.27 $1.43 Million - $1.49 Million	19,225	19,225 $1.65 Million

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burns J W & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Burns J W & CO Inc with notifications on news.

Account